US$ 23.57
glp-1 drugs ro Launches Wegovy® Pill Through Integration with Novo Nordisk It’s a pen. It’s a
Description
This review outlines the physiological role of amylin and highlights recent clinical studies exploring its therapeutic potential in diabetes and obesity
Amrico-Da-Silva L, Aguilera J, Quinteros-Waltemath O, Snchez-Aguilera P, Russell J, Cadagan C, et al

Arrone LJ et al
Obesity management often requires a multifaceted approach, including dietary modifications, exercise, medications, behavior therapy, and, in some cases, bariatric surgery